In this issue:
ABI-H0731, an HBV core inhibitor
HBV and HCV reactivation in psoriasis treated with biologics
Switching from TDF to TAF in chronic HBV
Antiviral therapy in second or third trimester for HBV transmission
Single-visit cure for chronic hepatitis C
HCV infection case finding, testing, and treatment
HBV outcomes after directacting antiviral therapy for HCV co-infection
Once- or twice-daily direct acting antiviral therapy for HCV
Long-term benefits of SVR in chronic HCV
Refusal of HBV birth-dose immunisation
Please login below to download this issue (PDF)